Clinical Trials Browser

Phase 2 × Myasthenia Gravis × apraclonidine × Clear all

NCT05045248 2021-09-16

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

Phase 2 Completed

Myasthenia Gravis